Niktimvo (axatilimab-csfr) is a first-in-class colony stimulating factor-1 receptor (CSF-1R)-blocking antibody approved for use in the U.S. for the treatment of chronic graft-versus-host disease (GVHD ...
Korro Bio saw its stock reach all-time lows on disappointing data for its lead pipeline candidate, while Intellia Therapeutics saw analyst downgrades on safety concerns despite releasing positive data ...
Rubrik posts strong FQ2 2026 growth with 57% cloud ARR, a growing customer base, and a data security role supporting upside.
Jacobin on MSNOpinion
In Utilities, a Culture of Graft Costs Consumers Billions
This week, utility regulators met at the annual “Let There Be Light” conference funded by major electric companies and data ...
1 小时on MSNOpinion
The Olympics comes to its senses on transgender athletes
The study of science has fallen on hard times over the past decade, as activists from all causes have twisted data and ...
Investing.com -- According to a recent Morgan Stanley report, hyperscalers are increasingly turning to finance leases for data center shells as part of an accelerated push to expand capacity for ...
The Wisconsin Department of Transportation (WisDOT) on Thursday hosted the fall meeting of the Wisconsin Automated Vehicle ...
Mega-cap technology, which has been the driving force behind the market’s advance, fell sharply as momentum strategies ...
The Department of Big Data Startup Business at Changwon National University held its annual general meeting on November 11 ...
The Apple ecosystem may be designed to provide streamlined experiences, but these open-source apps show there are other ...
DENVER -- Patients with advanced kidney cancer treated with immune checkpoint inhibitors (ICIs) lived longer if they consumed ...
SEATTLE, WA / ACCESS Newswire / November 13, 2025 / QorusDocs, a leader in AI-powered value and proposal management software, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果